Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 31 agosto?
Casi di morbillo negli Stati Uniti entro il 31 agosto?
NUOVO
31 ago 2026
2400+
98%
2450+
92%
2500+
82%
2550+
53%
2600+
56%
$647 Vol.
2400+
$482 Vol.
98%
2450+
$125 Vol.
92%
2500+
$0 Vol.
82%
2550+
$29 Vol.
53%
2600+
$10 Vol.
56%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Jul 31, 2026, 10:25 AM ET
Volume
$647Data di fine
31 ago 2026Mercato aperto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$647Data di fine
31 ago 2026Mercato aperto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Recent CDC data show 2,371 confirmed U.S. measles cases through July 30, 2026—already exceeding the full-year 2025 total of 2,289—with 93 percent tied to 35 outbreaks and 92 percent occurring in unvaccinated or unknown-status individuals. High transmissibility (basic reproduction number 12–18) sustains chains in under-vaccinated communities, while declining routine MMR coverage has eroded herd immunity thresholds. Weekly CDC surveillance releases and any new state-level outbreak declarations through late August will shape the final count; continued daily case accrual of roughly 30–50 would push totals well above recent historical peaks by month-end. Trader positioning reflects this trajectory alongside uncertainty over targeted public-health interventions.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti